On 29 de out. de 2025, ATRC reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 91.46% surprise. Revenue reached 134.27 milhão, compared to an expected 133.88 milhão, with a 0.29% difference. The market reacted with a -3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of -0.09 USD, with revenue projected to reach 142.05 milhão USD, implying an aumentar of 800.00% EPS, and aumentar of 5.80% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Veru Inc.
Report Date
17 de dez. de 2025 Para Q4 25
Estimativa
-$0.43
Real
$0.10
Surpresa
+123.07%
FAQ
What were AtriCure, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AtriCure, Inc. reported EPS of -$0.01, beating estimates by 91.46%, and revenue of $134.27M, 0.29% above expectations.
How did the market react to AtriCure, Inc.'s Q3 2025 earnings?
The stock price moved down -3.81%, changed from $35.44 before the earnings release to $34.09 the day after.
When is AtriCure, Inc. expected to report next?
The next earning report is scheduled for 10 de fev. de 2026.
What are the forecasts for AtriCure, Inc.'s next earnings report?
Based on 11
analistas, AtriCure, Inc. is expected to report EPS of -$0.09 and revenue of $142.05M for Q4 2025.